Description |
Product Type |
Product Size |
Injection
|
10'S |
Product Company |
Bajwa Pharmaceutical |
Metoclopramide Hcl 10mg
|
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Sandoz |
|
Product Type |
Product Size |
Drops |
1'S |
Product Company |
ICI Pakistan |
Nystatin 50ml |
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Sandoz |
|
Product Type |
Product Size |
Tablet |
30'S |
Product Company |
Sanofi |
Furosemide and amiloride 5mg |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Pfizer
|
Carboplatin 150mg/15ml
|
Content | Metoclopramide is a dopamine receptor antagonist and has been approved by the FDA to treat nausea and vomiting in patients with gastroesophageal reflux disease or diabetic gastroparesis by increasing gastric motility. It is also used to control nausea and vomiting in chemotherapy patients.
| Gemcitabine is a cytidine analog with two fluorine atoms.As a prodrug, gemcitabine is transformed into its active metabolites that work by replacing the building blocks of nucleic acids during DNA elongation, arresting tumour growth and promoting apoptosis of malignant cells. | Nystatin is an antifungal medicine and not an antibiotic. It makes holes in the cell membrane of the fungus and the contents leak out. This kills the fungus and treats the infection. If you're taking nystatin to prevent an infection, the medicine kills any fungus as it starts to appear.
| Oxaliplatin is a platinum based chemotherapy agent used to treat carcinoma of the colon or rectum or stage III colon cancer. | A combination of Furosemide and Amiloride is a diuretic which reduces the potassium loss of furosemide alone while avoiding the possible gastro-intestinal disturbances of potassium supplements.
| Carboplatin is a platinum-containing chemotherapy medicine, which belongs to the alkylating agents group of medicines. It is used to treat various cancers. It prevents growth of cancerous cells by damaging their DNA that aids in its proliferation.
|
Reviews
There are no reviews yet.